Intestinal Barrier in Post-Campylobacter jejuni Irritable Bowel Syndrome
Biomolecules · 28.02.2023 · 13 (3) · 449
DOI: 10.3390/biom13030449 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 28.02.2023. Verfasst von Sholpan Omarova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Physiology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, 12203 Berlin, Germany. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Campylobacter jejuni, Campylobacter Infections. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Sonnenfeld-Stiftung Berlin, German Federal Ministry of Education and Research (BMBF).
Abstract (Originalsprache)
Background
Campylobacter jejuni (C. jejuni) is one of the most common causes of bacterial gastroenteritis worldwide. One sequela of this infection is the development of post-infectious irritable bowel syndrome (PI-IBS). It has been suggested that a dysfunctional intestinal barrier may promote IBS development. We aimed to test this hypothesis against the background of the leaky gut concept for low-grade inflammation in PI-IBS.
Methods
We identified patients with persistent PI-IBS symptoms after C. jejuni infection. During sigmoidoscopy, forceps biopsies were obtained for electrophysiological measurements of epithelial transport and barrier function in miniaturized Ussing devices. C. jejuni absence was checked by PCR and cytokine production with immunohistochemistry.
Results
In PI-IBS, the epithelial resistance of the colon epithelium was unaltered, reflecting an intact paracellular pathway. In contrast, temperature-dependent horseradish peroxidase (HRP, 44 kDa) permeation increased. Short-circuit current (Isc) reflecting active anion secretion and ENaC-dependent electrogenic sodium absorption was unaffected. Early endosome antigen-1 (EEA1) and IL-4 levels increased. C. jejuni is not incorporated into the resident microbiota of the colon mucosa in PI-IBS.
Conclusions
In PI-IBS after C. jejuni infection, macromolecule uptake via endocytosis was enhanced, leading to low-grade inflammation with pro-inflammatory cytokine release. The findings will allow C. jejuni-induced pathomechanisms to be targeted during infection and, thereafter to reduce sequelae such as PI-IBS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Physiology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, 12203 Berlin, Germany.
- Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, 12203 Berlin, Germany.
- Department of Veterinary Medicine, Center for Veterinary Public Health, Institute of Food Safety and Food Hygiene, Freie Universität Berlin, 14163 Berlin, Germany.
ORCID-Profile: Verena Moos, Jörg-Dieter Schulzke, Roland Bücker
Förderung
- Deutsche Forschungsgemeinschaft
- Sonnenfeld-Stiftung Berlin
- German Federal Ministry of Education and Research (BMBF)
Zitieren
APA
Omarova, S., Awad, K., Moos, V., Püning, C., Gölz, G., Schulzke, J. D., & Bücker, R. (2023). Intestinal Barrier in Post-Campylobacter jejuni Irritable Bowel Syndrome. Biomolecules, 13(3), 449. https://doi.org/10.3390/biom13030449
Vancouver
Omarova S, Awad K, Moos V, Püning C, Gölz G, Schulzke JD, et al. Intestinal Barrier in Post-Campylobacter jejuni Irritable Bowel Syndrome. Biomolecules. 2023;13(3):449. doi:10.3390/biom13030449
BibTeX
@article{Omarova2023,
author = {Omarova, Sholpan and Awad, Karem and Moos, Verena and Püning, Christoph and Gölz, Greta and Schulzke, Jörg-Dieter and Bücker, Roland},
title = {Intestinal Barrier in Post-Campylobacter jejuni Irritable Bowel Syndrome},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {3},
pages = {449},
doi = {10.3390/biom13030449}
}
EUVIMED